PraetegoMar 1, 2023FUNDING AWARDSPraetego Awarded $0.3M by National Eye Institute to Advance Novel Oral Drug for Diabetic RetinopathyPraetego Inc, a pharmaceutical company protecting patients from neurodegenerative diseases related to aging, is pleased to announce a $0.3M